Gale Rudlaff

Scientist II - Rare Disease Research at Novo Nordisk

Gale Rudlaff, PhD, currently serves as a Scientist II in Rare Disease Research at Novo Nordisk since August 2024. As a co-founder of Fly Together Fitness since March 2019, Gale has been involved in business development, executing strategies for community events and marketing. Previous experience includes positions as Editing Scientist II at Transition Bio, Inc., where Gale led gene editing initiatives, and Scientist I at Metagenomi, focusing on genome editing assays. A former postdoctoral fellow at the University of California, San Francisco, Gale advanced light sheet microscopy protocols. Academic credentials include a PhD in Biological and Biomedical Sciences from Harvard University and dual Bachelor of Science degrees in Microbiology and History, Philosophy, and Sociology of Science from Michigan State University.

Links

Previous companies

Metagenomi logo
New York University logo
Michigan State University logo
Brown University logo
Institut Jacques Monod/CNRS & University Paris Diderot logo
Harvard University logo
Transition Bio logo